Indications:
Acute, uncomplicated influenza in patients 18 years and older who have been symptomatic for less than 2 days
Place in therapy:
Rapivab should be used in patients who:
test positive for the influenza virus
have symptoms for less than 48 hours AND
are unable to tolerate inhaled or PO medication